Economic Impact of Universal Hepatitis C Virus Testing for Middle-Aged Adults Who Inject Drugs.

ABSTRACT:

Introduction

The objective of this study was to estimate the economic impact of providing universal hepatitis C virus testing in commercially insured middle-aged persons who inject drugs in the U.S.

Methods

This study developed a dynamic 10-year economic model to project the clinical and economic outcomes associated with hepatitis C virus testing among middle-aged adult persons who inject drugs, from a payer's perspective. Costs related to hepatitis C virus testing, direct-acting antiviral, and liver-related outcomes between the (1) current hepatitis C virus testing rate (i.e., 8%) and (2) universal hepatitis C virus testing rate (i.e., 100%) were compared. Among patients testing positive, 21% of those without cirrhosis and 48% of those with cirrhosis were assumed to initiat

SUBMITTER: Jiang X 

PROVIDER: S-EPMC10074824 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature